Results 211 to 220 of about 549,826 (262)

Global, regional, and National burden of hepatitis C from 1990 to 2021 and projections until 2030. [PDF]

BMC Infect Dis
Bai J, Lv H, Wang L, You S, Liu D, Wang L, Xu Y, Lu J, Zhang W.   +8 more
europepmc   +1 more source

Anxiety and Depression Among Hepatitis B Inpatients in Shenzhen, China: A Cross-Sectional Study. [PDF]

Alpha Psychiatry
Chen Y, Duan G, Wang T, Wang X, He T, Liu T, He Y, Liu X, Lu H.   +8 more
europepmc   +1 more source

Expanding the spectrum of chronic hepatitis E in kidney transplantation: first report of HEV-3ra infection and review of literature. [PDF]

Front Med (Lausanne)
Matias EF, Azevedo M, Sampaio S, Pinho AT, Conde S, Rebelo S, Santos-Silva S, Nascimento MSJ, Mesquita JR, Santos L.   +9 more
europepmc   +1 more source

Data to Monitor Viral Hepatitis Elimination in the United States. [PDF]

Public Health Rep
Casillas SM, Hoots BE, Gupta N.
europepmc   +1 more source

Pre‐diagnostic immunological markers of bacterial translocation and liver cancer risk: A nested case–control analysis of 12 prospective cohorts

International Journal of Cancer, EarlyView.
What's New? Disruption of the gut–liver axis has been suggested to play an important role in liver carcinogenesis. However, limited prospective research has explored associations between potentially harmful gut‐derived bacterial products and liver cancer risk.
Cody Z. Watling, Peter T. Campbell, Barry I. Graubard, Yanyu Wang, Andrew T. Gewirtz, Xuehong Zhang, Matthew J. Barnett, Julie E. Buring, Yu Chen, A. Heather Eliassen, J. Michael Gaziano, Jonathan N. Hofmann, Wen‐Yi Huang, Jae H. Kang, Jill Koshiol, Erikka Loftfield, I‐Min Lee, Steven C. Moore, Lorelei A. Mucci, Marian L. Neuhouser, Christina C. Newton, Mark P. Purdue, Howard D. Sesso, Martha Shrubsole, Rashmi Sinha, Lesley Tinker, Matthew Triplette, Caroline Y. Um, Kala Visvanathan, Eleanor L. Watts, Jean Wactawski‐Wende, Walter Willett, Fen Wu, Wei Zheng, Dinesh Barupal, Jessica L. Petrick, Katherine A. McGlynn   +36 more
wiley   +1 more source

Comparative analysis of non-invasive fibrosis markers: Insights from chronic HBV, HBV+HDV, and HCV infections. [PDF]

Infect Med (Beijing)
Khikmatullaeva AS, Brigida KS, Мirrakhimova NM, Аbdukadirova MA, Ibadullaeva NS, Bayjanov AK, Kan NG, Khodjaeva ME, Yarmukhamedova NA, Mirzaev UK.   +9 more
europepmc   +1 more source

Controlled trial of cervical cancer screening frequency among human‐papillomavirus‐vaccinated women

International Journal of Cancer, EarlyView.
What's New? Since the introduction of the human papillomavirus (HPV) vaccine in 2006, vaccine‐type infections have declined markedly. As nonvaccine HPV types generally carry lower oncogenic potential, this shift warrants reevaluation of cervical screening regimens.
Mònica Ortega Llobet, Penelope Gray, Iacopo Baussano, K. Miriam Elfström, Tiina Eriksson, Camilla Lagheden, Pekka Nieminen, Anna Söderlund‐Strand, Joakim Dillner, Ville N. Pimenoff, Matti Lehtinen   +10 more
wiley   +1 more source

Hepatitis B and chronic kidney disease: Bench to bedside. [PDF]

World J Nephrol
Singh S, Singh R, Kaul A, Goel A.
europepmc   +1 more source

Cancer risks and trends between 1997 and 2018, and effects of restored immunity in people living with HIV: Results from the ANRS CO4 French hospital database on HIV

International Journal of Cancer, EarlyView.
What's New? This large nation‐wide cohort study provides a comprehensive 20‐year analysis of cancer trends among people living with HIV in France, highlighting persistent excess risks for virus‐related cancers despite effective antiretroviral therapy and immune restoration.
Sophie Grabar, Paula Lakrout, Valérie Potard, Aurélien Belot, Jacques Cadranel, Christine Jacomet, Christine Katlama, Esaïe Marshall, Olivier Lambotte, Romain Palich, Sylvie Ronot‐Bregigeon, Jean‐Philippe Spano, Anne‐Marie Bouvier, Alain Makinson, Dominique Costagliola   +14 more
wiley   +1 more source